Tag Archives: Boehringer Ingelheim
-
-
Pradaxa Bleeding Reports Provide ‘Distorted Estimate’ of Risk: FDA Staff
-
Pradaxa Bleeding Death Five Times More Likely Than With Warfarin: Report
-
FDA Shuts Down Boehringer Ingelheim Plant Due to Quality Issues
-
Pradaxa Recall Issued Over Defective Bottles, Effectiveness Concerns
-
FDA Evaluation of Warfarin and Pradaxa Bleeding Risks Raises Questions
-
Pradaxa Lawsuit Trials Scheduled To Begin in August 2014
-
Bleeding Risk with Newer Blood Thinners Diminish Benefits: Study
-
Mirapex Side Effects Could Increase Risk of Heart Failure, FDA Warns
-
Attorneys Seek Leadership Roles in Pradaxa Litigation, As Stay Issued